IRRAS
Develops and commercializes fluid management solutions for neurocritical care.
IRRAS | ST
Overview
Corporate Details
- ISIN(s):
- SE0008321202
- LEI:
- 549300EKKVQN2J25MJ59
- Country:
- Sweden
- Address:
- VASAGATAN 16, 111 20 Stockholm
- Website:
- https://irras.com/
- Sector:
- Manufacturing
Description
IRRAS is a commercial-stage medical technology company focused on designing, developing, and commercializing innovative solutions for neurocritical care. The company's core technology addresses challenges in fluid control and management for critically ill patients, particularly those with intracranial bleeding. Its primary product, the IRRAflow system, is an intelligent fluid management device that combines controlled irrigation with drainage to manage fluids and monitor intracranial pressure. The system is designed to improve patient outcomes, reduce complications, and decrease the overall cost of care by providing a new standard for treating brain pathologies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-20 17:46 |
IRRAS’s application for delisting has been approved and the Board of Directors …
|
English | 126.4 KB | ||
| 2023-10-20 17:46 |
IRRAS ansökan om avnotering har godkänts och styrelsen har fattat beslut om att…
|
Swedish | 125.5 KB | ||
| 2023-10-20 00:06 |
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF IRRAS AB
|
English | 172.4 KB | ||
| 2023-10-20 00:06 |
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IRRAS AB
|
Swedish | 186.8 KB | ||
| 2023-10-16 18:30 |
IRRAS publishes prospectus
|
English | 1.7 MB | ||
| 2023-10-16 18:30 |
IRRAS offentliggör prospekt
|
Swedish | 1.7 MB | ||
| 2023-10-16 13:14 | English | 35.3 KB | |||
| 2023-10-15 21:45 |
IRRAS has extended maturity date for its SEK 20 million short-term loan
|
English | 71.9 KB | ||
| 2023-10-15 21:45 |
IRRAS har senarelagt förfallodagen för dess kortfristiga lån om SEK 20 miljoner
|
Swedish | 86.6 KB | ||
| 2023-10-13 18:00 |
Kommuniké från extra bolagsstämma i IRRAS AB (publ) den 13 oktober 2023
|
Swedish | 104.6 KB | ||
| 2023-10-13 18:00 |
Bulletin from the Extraordinary General Meeting in IRRAS AB (publ) on 13 Octobe…
|
English | 138.2 KB | ||
| 2023-09-18 20:31 |
Statement by the Board of Directors of IRRAS AB
|
English | 201.2 KB | ||
| 2023-09-18 20:30 |
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IRRAS AB (PUBL)
|
Swedish | 187.2 KB | ||
| 2023-09-15 08:00 |
IRRAS säkrar utökad bryggfinansiering
|
Swedish | 186.1 KB | ||
| 2023-09-15 08:00 |
IRRAS Secures Extended Short-Term Loan Agreement
|
English | 157.8 KB |
Automate Your Workflow. Get a real-time feed of all IRRAS filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IRRAS
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IRRAS via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-10-13 | Marios Fotiadis | Other | Other | 338,264,840 | 60,887,671.20 SEK |
| 2023-09-18 | Marios Fotiadis | Other | Buy | 9,185,346 | 1,653,362.28 SEK |
| 2023-09-04 | MARIOS FOTIADIS | Other | Sell | 1,277,700 | 229,986.00 SEK |
| 2021-06-11 | Bacara Holdings Limited | Other | Other | 3,500,000 | 17,500,000.00 SEK |
| 2021-06-11 | Kleanthis Xanthopoulos | Other | Other | 200,000 | 1,000,000.00 SEK |
| 2021-05-04 | Sabina Berlin | Other | Buy | 8,532 | 49,997.52 SEK |
| 2020-09-24 | Carl Martin | Other | Buy | 14,859 | 99,950.55 SEK |
| 2020-09-22 | Carl Martin | Other | Buy | 5,141 | 33,365.09 SEK |
| 2020-04-09 | Anders Paul Wiklund | Other | Other | 17,134 | 99,377.20 SEK |
| 2020-04-09 | Sabina Berlin | Other | Other | 7,280 | 42,224.00 SEK |
Peer Companies
